Business Description
Rua Bioscience Ltd
ISIN : NZRUAE0004S1
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.88 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.66 | |||||
Beneish M-Score | -38.08 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44 | |||||
9-Day RSI | 42.55 | |||||
14-Day RSI | 43.05 | |||||
6-1 Month Momentum % | -51.39 | |||||
12-1 Month Momentum % | -60.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.24 | |||||
Quick Ratio | 10.66 | |||||
Cash Ratio | 5.8 | |||||
Days Inventory | 205.86 | |||||
Days Sales Outstanding | 477.89 | |||||
Days Payable | 405.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.44 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.04 | |||||
Operating Margin % | -3776.92 | |||||
Net Margin % | -5618.59 | |||||
FCF Margin % | -1415.38 | |||||
ROE % | -93.43 | |||||
ROA % | -87.55 | |||||
ROIC % | -76.07 | |||||
ROC (Joel Greenblatt) % | -232.85 | |||||
ROCE % | -62.45 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 35 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.4 | |||||
EV-to-EBIT | -0.75 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-Revenue | 28 | |||||
EV-to-FCF | -1.94 | |||||
Price-to-Net-Current-Asset-Value | 2.33 | |||||
Price-to-Net-Cash | 7 | |||||
Earnings Yield (Greenblatt) % | -134.51 | |||||
FCF Yield % | -39.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rua Bioscience Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NZ$) | 0.312 | ||
EPS (TTM) (NZ$) | -0.114 | ||
Beta | 0.52 | ||
Volatility % | 51.93 | ||
14-Day RSI | 43.05 | ||
14-Day ATR (NZ$) | 0.001502 | ||
20-Day SMA (NZ$) | 0.07285 | ||
12-1 Month Momentum % | -60.23 | ||
52-Week Range (NZ$) | 0.068 - 0.171 | ||
Shares Outstanding (Mil) | 158.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rua Bioscience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rua Bioscience Ltd Stock Events
Event | Date | Price(NZ$) | ||
---|---|---|---|---|
No Event Data |
Rua Bioscience Ltd Frequently Asked Questions
What is Rua Bioscience Ltd(NZSE:RUA)'s stock price today?
When is next earnings date of Rua Bioscience Ltd(NZSE:RUA)?
Does Rua Bioscience Ltd(NZSE:RUA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |